Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab versus methotrexate in pediatric chronic plaque psoriasis
2009-013072-52Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Sep 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of adalimumab and methotrexate in psoriasis (3 arms), sponsored by AbbVie Inc. Primary endpoint: PASI 75 response. Started Sep 2010; status: completed.
02
Drugs
adalimumabmethotrexate
03
Conditions
psoriasis
Beyond the preview
Go deeper on 2009-013072-52.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013072-52.